Statistics

Total Visits

Views
Comparative study of infliximab versus adalimumab in patients with refractory uveitis due to behcet's disease multicenter study of 125 cases31

Select a period of time:

Number of views in the range

Views
Comparative study of infliximab versus adalimumab in patients with refractory uveitis due to behcet's disease multicenter study of 125 cases20

Views

Views
October 20240
November 20240
December 20240
January 20254
February 20250
March 202516
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
United States3
United Kingdom1
 

Top cities views

Views
Los Angeles1